Top compounds associated with response to SH3YL1


Feature Type Standardized
Nominal ANOVA
mRNA Gefitinib GDSC1000 pan-cancer AAC 0.16 1e-05
mRNA Elesclomol GDSC1000 pan-cancer AAC -0.17 2e-05
mRNA TW 37 GDSC1000 pan-cancer AAC -0.16 2e-05
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 2e-05
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 3e-05
mRNA Erlotinib CTRPv2 pan-cancer AAC 0.16 4e-05
mRNA fluvastatin CTRPv2 pan-cancer AAC -0.17 4e-05
mRNA Panobinostat CCLE pan-cancer AAC 0.18 9e-05
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 0.0001
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 0.0001
Download CSV